• United Kingdom

Accepting PhD Students

PhD projects

Design and Development of Anti-Infective Drugs

If you made any changes in Pure these will be visible here soon.

Network

Federica Giordani

  • Wellcome Trust Centre for Molecular Parasitology, University of Glasgow
  • University of Glasgow

External person

Kirsten Gillingwater

  • Swiss Tropical and Public Health Institute
  • Swiss Tropical and Public Health Institute (Swiss TPH)
  • University of Basel

External person

Frank Brombacher

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Michael Barrett

  • University of Glasgow

External person

Lerato Hlaka

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Ryan J O Nichol

  • University of Strathclyde

External person

Reto Guler

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Harry P De Koning

  • University of Glasgow
  • Glasgow University
  • University of Glasgow
  • University of Glasgow

External person

Mumin Ozturk

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Sandra Duffy

  • Griffith University

External person

Michael-Jon Rosslee

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Jane C. Munday

  • Glasgow University

External person

Vicky Avery

  • Eskitis Institute, Griffith University, Brisbane, QLD 4111, Australia. t.grkovic@griffith.edu.au.

External person

Farideh Javid

  • University of Huddersfield

External person

Simon Allison

  • University of Huddersfield

External person

Kartheek Sooda

  • University of Huddersfield

External person

Andrew Jackson

  • Department of Renal Surgery

External person

Omar Hussain

  • University of Huddersfield

External person

Gemma Sweeney

  • University of Huddersfield

External person

Soumya Ramu

  • Community for Open Antimicrobial Drug Discovery (CO-ADD), Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia

External person

Christina Lünse

  • University of Bonn

External person

Günter Mayer

  • University of Bonn

External person

Suraj Parihar

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Doreen Sekibo

  • Centre for Biological Sciences, Life Science Building, University of Southampton, Southampton SO17 1BJ

External person

Margaret Harnett

  • University of Glasgow

External person

Santosh Kumar

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Roger Phillips

  • University of Huddersfield

External person

Santosh Kumar

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa
  • Heriot-Watt University

External person

Michael P. Barrett

  • University of Glasgow
  • Glasgow University

External person

David Rodgers

  • University of Glasgow
  • University of Glasgow

External person

Simbarashe B. Nyamini

  • University of Huddersfield

External person

Miguel Pineda

  • University of Glasgow

External person

Alysha Elliott

  • Community for Open Antimicrobial Drug Discovery (CO-ADD), Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia

External person

Henry J. Tait

  • University of Strathclyde

External person

Paula Duffy

  • University of Strathclyde

External person

Keith Fox

  • Centre for Biological Sciences, Life Science Building, University of Southampton, Southampton SO17 1BJ
  • Univ Southampton

External person

Rachel Crossdale

  • University of Sheffield

External person

Johannes Zuegg

  • Community for Open Antimicrobial Drug Discovery (CO-ADD), Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia

External person

Margaret M. Harnett

  • University of Glasgow

External person